Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Peter Powers is Named Chief Executive Officer of Memorial Regional Hospital


Peter Powers, CEO, Memorial Regional Hospital

“Starting in the middle of a global pandemic has offered me a unique perspective and has allowed me to experience firsthand the unwavering dedication of our staff and leadership,” Powers said.

Peter Powers, FACHE, has been named Administrator and Chief Executive Officer of Memorial Regional Hospital, the flagship hospital of Memorial Healthcare System. In his new role, Powers will oversee the 797-bed hospital, which is home to Memorial Cardiac and Vascular Institute, Memorial Transplant Institute, Memorial Cancer Institute, Memorial Neuroscience Institute and Comprehensive Stroke Center, The Family Birthplace and Level I Trauma Center.

Powers immediately integrated into the system’s activities, given his start aligned with Memorial’s public health management of the COVID-19 pandemic.

“Starting in the middle of a global pandemic has offered me a unique perspective and has allowed me to experience firsthand the unwavering dedication of our staff and leadership,” Powers said. “Our community relies on us during the toughest of times, and I am in awe of how the hospital and the system go above and beyond to offer exceptional healthcare services every day, and I’m honored to be part of the Memorial family.”

Powers joins Memorial after serving as Chief Executive Officer for St. Anthony Hospital, a Level 1 Trauma Center in Colorado, overseeing the development of service line strategies and operating plans to enhance patient care. He is credited for growing market share within St. Anthony Hospital’s tertiary and regional markets and significantly increasing physician and employee engagement. He succeeds Zeff Ross, FACHE, Executive Vice President of Memorial Healthcare System and Chief Executive Officer of Memorial Regional Hospital, who retired in December 2019, after serving in numerous leadership roles within Memorial Healthcare System since 1991.

Powers holds a Bachelor of Public Affairs with a minor in Business and Sociology from Indiana University and a Master of Business Administration with Distinction from the University of Sydney, Australia. He is a Fellow of the American College of Healthcare Executives (FACHE) and recently served on the Red Rocks Community College Advisory Board, Jefferson County Economic Development Commission Board of Directors and the American Heart Ball Executive Committee. Powers recently moved to Davie with his wife and two children.

“With his genuine, collaborative approach, we are confident that Peter will serve as a strong leader to help us overcome these unprecedented times and enter the next chapter in the history of Memorial Regional Hospital,” said Aurelio M. Fernandez, III, FACHE, Memorial Healthcare System President & Chief Executive Officer.

About Memorial Healthcare System

Memorial Healthcare System is one of the largest public healthcare systems (by revenue) in the U.S. and a national leader in quality care and patient satisfaction. Recently named the #1 healthcare brand in the U.S. (Monigle’s “Humanizing Brand Experience”), it features a patient and family-centered approach to care at facilities that include Memorial Regional Hospital, Memorial Regional Hospital South, Joe DiMaggio Children’s Hospital, Joe DiMaggio Children’s Health Specialty Center in Wellington, Memorial Hospital West, Memorial Hospital Pembroke, Memorial Hospital Miramar, and Memorial Manor nursing home. To learn more, visit mhs.net.

Share article on social media or email:

In Vitro Sciences Names Derek Larkin as New Chief Executive Officer


The In Vitro Sciences (IVS) Board of Directors announced today the placement of Derek M. Larkin as Chief Executive Officer. This appointment follows a recapitalization event by private equity firm, Sverica Capital Management, LP (Boston and San Francisco) and helps set IVS up for continued national expansion. During the past year IVS, a prominent network of fertility centers, also completed a spin-out from Women’s Health USA and acquired Advanced Fertility Care, a Phoenix, Arizona-based fertility clinic.

Derek comes to IVS with more than 20 years of executive leadership experience in both the pharmaceutical and healthcare fields. Most recently, Derek spent nearly 12 years as Chief Executive Officer of Boston IVF, one of the largest in vitro fertilization (IVF) practices in the U.S. In this role, Derek was fundamental in tripling the company’s revenue, initiating and launching a national chain of IVF centers and leading one of the largest mergers ever within the IVF category in the U.S. Derek was also instrumental in expanding the scope of the company’s capabilities from IVF alone to a comprehensive women’s health company, in partnership with other similar surgical specialties.

“We are fortunate to have someone of Derek Larkin’s caliber and experience to lead IVS. We are in the midst of transformative growth at IVS, and the addition of Derek to an already veteran team will be immensely valuable as we successfully implement our strategy and continue to grow in the market,” said Gregg Osenkowski, a partner at Sverica and a member of the IVS Board of Directors. “We find Derek to be extremely well-suited for this position. He is a proven leader and an experienced CEO and is well-positioned to lead IVS’s continued transformation. Derek has a strong strategic track record in implementing change and driving results.”

“I’m honored and thrilled to join the team at IVS and to help lead our collective growth efforts. I have deep respect for all the work that has taken place at IVS, and I look forward to working closely with the board, members of the management team, and team members,” adds Larkin. “Together, we will mark a new path for growth for IVS.”

About In Vitro Sciences

With a 23-year history in the fertility arena and a comprehensive suite of business management services, In Vitro Sciences (IVS) partners with reproductive endocrinology practices across the United States. IVS got its start in partnership with Women’s Health USA, a national management service organization supporting more than 600 ObGyn providers around the U.S. IVS offers strategic management services for independent practices, including:

implementing creative growth strategies supporting streamlined operational costs, payer alignment, merger and acquisition plans, marketing, and risk management services. Its unique partnership model enables physicians and physician groups to maintain their independence while leveraging the resources of a national organization.

Share article on social media or email:

Otology & Neurotology Fellows to Convene for Fifth Annual Advanced Course in Ear & Skull Base Surgery This Fall


CME Outfitters (CMEO), a leading accredited provider in continuing medical education, is excited to announce an upcoming educational and professional development opportunity for current otology and neurotology fellows. The fifth annual Otology Fellows Congress and Advanced Course in Ear & Skull Base Surgery will be taking place October 23-25, 2020 at the Yasargil Surgical Skills Laboratory & Education Center at the University of Arkansas for Medical Sciences in Little Rock.

This unique meeting will feature lectures, extensive laboratory dissections, and ample networking opportunities that will provide fellows with an opportunity to focus on some advanced surgical techniques that are well beyond the scope of a typical temporal bone course, while also working alongside fellows from the USA and abroad. Upwards of ten renowned teaching faculty members, including international distinguished members, will be in attendance to guide the fellows throughout this course and provide expert insights. Thanks to robust financial support, CME Outfitters is able to accommodate 24 fellows from the United States and abroad free of charge, with lodging and meal expenses also covered.

Each attendee will have access to half of a whole head specimen, as well as two temporal bones. Attendees will be covering topics such as soft tissue flaps in tympanomastoid surgery, revision stapes surgery, endoscopic ear surgery, and difficult cochlear implant cases/cochlear ossification. Additionally, this course offers dissection sessions on a variety of lateral skull base approaches including infratemporal fossa, complex middle ear and advanced cochlear implant techniques, meatoplasty, jugular foramen approaches, petrous apex approaches, and more.

Registration is now open on a ‘first come, first served’ basis, so fellows are encouraged to register as soon as possible. For more information, or to get registered, visit https://www.cmeoutfitters.com/otologyfellowscourse2020.

The deadline to sign up is August 21, 2020.

Visit https://www.cmeoutfitters.com to stay up to date on the latest content and updates from this initiative.

About CME Outfitters, LLC

CME Outfitters develops, distributes and certifies continuing education activities that focus on the integration of the multidisciplinary care team to ensure the best care of patients. Our educational interventions include live meetings, interactive webcasts, medical simulations, infographics, and other innovative formats that leverage the latest in technology to optimize the learning environment and promote clinician and patient behavior changes. CME Outfitters also offers expert accreditation and outcome services for non-accredited organizations. CME Outfitters focuses on education to specialty audiences, with strong expertise in neuroscience, inflammatory, infectious, and autoimmune diseases, and cardiovascular disease. For a complete list of certified activities and more information, visit https://www.cmeoutfitters.com or call 877.CME.PROS (877.263.7767).

Share article on social media or email:

Customers help Dutch Bros Coffee raise $1.39 million to help end ALS


Drink One for Dane mugs and sticker

Dutch Bros Coffee and its customers joined together on its annual Drink One for Dane day to raise more than $1.39 million to #endALS

“There’s a lot going on in the world right now, but that doesn’t change the need to end ALS. Our customers and broistas really are amazing and are truly making a massive difference in the lives of so many.”

Dutch Bros Coffee and its customers joined together to raise $1.39 million for the Muscular Dystrophy Association (MDA) on the company’s 14th annual Drink One For Dane day held on May 8. More than 390 shops in seven states joined together with customers to support ALS research, patient care and advocacy.

“We’re so grateful to everyone who went online or came out to support Drink One for Dane this year,” said Travis Boersma, CEO and co-founder of Dutch Bros Coffee. “There’s a lot going on in the world right now, but that doesn’t change the need to end ALS. Our customers and broistas really are amazing and are truly making a massive difference in the lives of so many.”

In addition to a portion of proceeds donated from daily shop sales, Dutch Bros also offered an online option to give with $50,000 raised from the sale of a specialty mug and sticker package.

Since 2007, Dutch Bros and its customers have raised more than $8.4 million to help support ALS patients and find a cause and cure for the disease.

“This is a testament to the purpose-driven, caring culture of Dutch Bros. Their commitment to unlocking a cure for ALS—a devastating disease that took the life of Dutch Bros co-founder Dane Boersma–is remarkable. Our longstanding partnership with Dutch Bros carries on his legacy. We have a shared mission to protect and care for ALS patients as we work to discover a cure,” said Lynn O’Connor Vos, president and CEO of MDA.

The funds raised support the MDA, a world leader in ALS research, treatments, care and advocacy. Dutch Bros began supporting the organization after co-founder Dane Boersma was diagnosed with Amyotrophic Lateral Sclerosis (ALS), a fatal disease that affects the parts of the nervous system that are responsible for muscle movement. There is currently no cure for the disease.

The MDA produces and distributes resources and provides support for patients and their families through a nationwide network of 150 MDA Care Centers. The MDA has partnered with Dutch Bros since the very first Drink One for Dane fundraiser in 2007.

About Dutch Bros

Dutch Bros Coffee is the country’s largest privately held drive-thru coffee company, with more than 380 locations and 12,000 employees in seven states. The company is headquartered in Grants Pass, Oregon, where it was founded in 1992 by Dane and Travis Boersma. Dutch Bros serves specialty coffee, smoothies, freezes, teas, a private-label Dutch Bros Blue Rebel energy drink and nitrogen-infused cold brew coffee. Its rich, proprietary coffee blend is handcrafted from start to finish.

In addition to its mission of speed, quality and service, Dutch Bros is committed to giving back to the communities it serves. Through its Dutch Bros Foundation and local franchisees, Dutch Bros donates millions of dollars each year to causes across the country.

To learn more about Dutch Bros, visit http://www.dutchbros.com, like Dutch Bros Coffee on Facebook or follow @DutchBros on Twitter.

About MDA

For 70 years, the Muscular Dystrophy Association (MDA) has been committed to transforming the lives of people living with muscular dystrophy, ALS, and related neuromuscular diseases. We do this through innovations in science and innovations in care. As the largest source of funding for neuromuscular disease research outside of the federal government, MDA has committed more than $1 billion since our inception to accelerate the discovery of therapies and cures. Research we have supported is directly linked to life-changing therapies across multiple neuromuscular diseases. MDA’s MOVR is the first and only data hub that aggregates clinical, genetic, and patient-reported data for multiple neuromuscular diseases to improve health outcomes and accelerate drug development. MDA supports the largest network of multidisciplinary clinics providing best in class care at more than 150 of the nation’s top medical institutions. Our Resource Center serves the community with one-on-one specialized support, and we offer educational conferences, events, and materials for families and healthcare providers. Each year thousands of children and young adults learn vital life skills and gain independence at summer camp and through recreational programs, at no cost to families. During the COVID-19 pandemic, MDA continues to produce virtual events, programming, and advocacy to support our community when in-person events and activities are not possible. MDA’s COVID-19 guidelines and virtual events are posted at mda.org/COVID19. For more information, visit mda.org.

Share article on social media or email:

Aspirion Rated a Top Performer in First-Ever Complex Claims KLAS Report


KLAS Customer Experience Pillars

“We’re honored to be recognized among industry leaders,” says Aspirion CEO Jason Erdell. “While I have been associated with many KLAS-reviewed organizations, our 93.1 is the highest rating I have experienced.”

Aspirion, an industry-leading provider of complex claims management services, scored a 93.1 in the KLAS report for complex claims published May 12, 2020. This year is the first time the complex claims category has been reviewed by KLAS.

“We’re honored to be recognized among industry leaders,” says Aspirion CEO Jason Erdell. “While I have been associated with many KLAS-reviewed organizations, our 93.1 is the highest rating I have experienced. We are grateful that our clients view our service performance among that of an elite group of admired industry leaders.”

Each year KLAS interviews thousands of healthcare professionals to produce vendor performance reviews. As complex claims become increasingly critical to healthcare reimbursement, hospital systems are more frequently enlisting partners that specialize in these unique and complicated claims. KLAS’s recognition of this dynamic was foundational to creating this new KLAS category.

Aspirion earned scores higher than 90 in all five KLAS Customer Experience Pillars and was the top fully-rated partner in complex claims’ quality/strategy matrix.

“We are committed to listening to and learning from our clients in order to fine-tune our current support and to enhance our ever-expanding technology roadmap,” says Erdell. “Our KLAS reviews suggest that our clients recognize and appreciate our intense focus on innovation and continuous improvement. We are resolute in our belief that, as we remain committed to enhance our infrastructure, we will produce better results and even higher client satisfaction.”

To learn more about Aspirion’s services, visit aspirion.com.

About Aspirion

Aspirion helps hospitals and physicians recover otherwise lost claims revenue from motor vehicle accidents, workers compensation, the Veteran’s Administration, and Tricare as well as out-of-state Medicaid, Medicaid eligibility, underpayments and denials. Aspirion’s experienced team of healthcare, legal, and technical professionals combined with industry-leading technology platforms help ensure that providers receive their Complex RCM revenue so that providers, hospitals, and their staff can focus on patient care.

Share article on social media or email:

Study Finds Pandemic Likely to Negatively Impact Biopharmaceutical Sector


News Image

“There may be humanitarian reasons why companies choose not to profit from their treatments. But policymakers should also be aware that threats to intellectual property create significant disincentives to investment,” said Pioneer Executive Director Jim Stergios.

Threats to intellectual property, political pressure to lower prices, disruption of clinical trials will cause long-term harm

Contrary to conventional wisdom that says the coronavirus pandemic will generally benefit biopharmaceutical companies, a new Pioneer Institute study finds many companies will emerge from the pandemic commercially weaker, dealing with delays in new product launches and with fewer resources to invest in research and development.

“There will certainly be worldwide demand for COVID-19 treatments,” said William Smith, author of “The Negative Impact of COVID-19 Upon the Biopharmaceutical Sector.” “But they will also require massive investments in clinical development and manufacturing, and political pressure on pricing makes it impossible for companies to recoup those investments.”

Cipro is an antibiotic well-suited to treat anthrax, which began arriving in mailboxes in the weeks after September 11, 2001. The Centers for Disease Control recommended that patients exposed to the bacteria take Cipro twice a day for 60 days. Despite the fact that the entire course of treatment would only cost $219, Bayer agreed to cut the price in half after then-U.S. Secretary of Health and Human Services threatened to take away the company’s patent.

More recently, when Gilead announced it would invest $1 billion in Remdesivir, a promising COVID-19 treatment, one would have thought the company’s stock would rise. Instead, it fell 5 percent. A number of analysts remarked that the reason was fears that political pressure would result in very low prices or threats to Gilead’s patent.

Some investors and industry leaders may conclude that investments in major public health emergencies should be avoided in favor of research on lifestyle treatments or medications for less serious conditions that aren’t accompanied by threats to intellectual property or pressure to reduce prices.

Political pressure to cut prices is likely to be most acute in the area of vaccines, where the federal government is providing grants to companies such as Johnson & Johnson and Moderna. Many policy makers will likely see any new vaccine that emerges from research that was partially funded by the government as public property.

“There may be humanitarian reasons why companies choose not to profit from their treatments,” said Pioneer Executive Director Jim Stergios. “But policymakers should also be aware that threats to intellectual property create significant disincentives to investment.”

In 2018, Massachusetts institutions received nearly $3 billion in National Institutes of Health funding, the second highest amount among the states. That same year, private venture companies invested $4.8 million the Commonwealth’s life sciences companies. In terms of new businesses, more than a third of U.S.-based biotechs that went public in the first half of 2019 were Massachusetts-based.

These companies also face delays in clinical trials for non-COVID-19 treatments, which could significantly disrupt long-term product pipelines. Since firms typically file patents before clinical trials begin, significant delays eat up the period during which treatments can be sold under patent before opening up to competition from generic makers.

The delays are particularly damaging to small firms, whose future may depend on a successful trial.

Smith’s recommendations include extending patent life on products by the period clinical trials were delayed by the pandemic, and that COVID-19 treatments in which companies made significant investments should be priced to allow a reasonable return on that investment.

About the Author

Dr. William S. Smith is Visiting Fellow in Life Sciences at Pioneer Institute. He writes about public policy issues impacting the life sciences industry with particular emphasis upon pharmaceuticals. Dr. Smith has 25 years of experience in government and in corporate roles. He spent ten years at Pfizer as Vice President of Public Affairs and Policy. He later served as a consultant to major pharmaceutical, biotechnology and medical device companies, and was President of a small medical device company for three years. His career has also included senior staff positions for the Republican House leadership on Capitol Hill, the White House, and in the Governor’s office in Massachusetts. He is affiliated as Research Fellow and Managing Director with the Center for the Study of Statesmanship at The Catholic University of America (CUA). He earned his PhD at CUA and a bachelor’s degree from Georgetown University.

About Pioneer

Mission

Pioneer Institute develops and communicates dynamic ideas that advance prosperity and a vibrant civic life in Massachusetts and beyond.

Vision

Success for Pioneer is when the citizens of our state and nation prosper and our society thrives because we enjoy world-class options in education, healthcare, transportation and economic opportunity, and when our government is limited, accountable and transparent.

Values

Pioneer believes that America is at its best when our citizenry is well-educated, committed to liberty, personal responsibility, and free enterprise, and both willing and able to test their beliefs based on facts and the free exchange of ideas.

Share article on social media or email:

Summit Medical Hits Milestone to Deliver 1 Million FDA-Compliant Face Shields to Protect Health Care Workers — and Returning Business Employees — From Spread of COVID-19


Medical professional wearing Summit Medical professional face shield.

Our team’s innovative design and dedication to meet the urgent demand to protect health care workers as well as employees returning to the workplace has been outstanding.

Summit Medical, an Innovia Medical company, a medical device manufacturer, announces its first milestone to deliver over one million FDA-compliant face shields — designed, engineered and manufactured in the United States in just eight weeks. Summit Medical Face Shields meet the critical need for personal protective equipment (PPE) for both front-line health care workers and returning business employees to limit the spread of COVID-19 as the country reopens.

As the demand for the company’s elective surgical products declined with the onset of the coronavirus, Summit Medical’s successful pivot to manufacture face shields has also met a critical economic need to protect its 65 employees with job security.

“Our team’s innovative design and dedication to meet the urgent demand to protect health care workers as well as employees returning to the workplace has been outstanding,” said Kevin McIntosh, President of Summit Medical. McIntosh mitigated employee losses by cross-training staff to assemble face shields. “Every staff member has been involved in production and is working overtime, including weekends, to make it possible to deliver face shields with quality and speed.”

Unlike masks, Summit Medical’s Face Shields protect all facial mucous membranes — including the eyes — from splashes, sprays, droplets and fine aerosol contamination of the coronavirus. Easy to see through and breathe in, the clear plastic shield enables full-face coverage (9 inches long). In addition, shields are usually more comfortable to wear than masks and they form a barrier that keeps people from easily touching their own faces.

“Our engineering team adjusted an open-source design from Maker Space at the University of Wisconsin-Madison to meet requirements for Summit Medical’s Face Shields to be registered and sold as a medical device,” said Tim Butina, Summit Medical’s Engineering & Operations Manager. “More importantly, we did extensive research and testing of materials to ensure Summit Medical was providing a high quality, safe product.”

The Need for Face Shields Beyond Health Care

As businesses reopen and adopt new COVID-19 protocols, the effectiveness of face shields in health care demonstrates their utility to protect workers in other industries. “As we continue to supply the health care community, Summit Medical’s Face Shields also offers a cost-effective way to protect employees returning to the office, sales floor, warehouse or industrial production floor,” said McIntosh.

“I’ve been searching for an answer for my production staff that was functional and provides protection from the COVID-19 virus,” said Todd Wiles, Director of Operations at Water Control Corporation in Ramsey, Minn. “My staff has been wearing Summit Medical’s Face Shields for over a week now and report they are very comfortable.”

Face shields enable full visibility of the face and mouth — a particular advantage for service industries with staff who directly interact with customers such as retail stores and restaurants. Businesses also can tap Summit Medical’s expertise working with OEM customers to quickly brand face shields with their own corporate logos.

“We require all of our employees to wear some type of protective face cover. Most work in an environment where the temperature is elevated at best,” said Shelli Raes, Office Manager for Bob’s Produce Ranch in Fridley, Minn. “Summit Medical’s Face Shields help to keep employees cooler than a face mask.” In addition, when speaking, people sometimes pull down a mask to communicate better, but that isn’t necessary with a facial shield, as a clear shield allows for visibility of facial expressions and lip movement for speech perception.

Leveraging Minnesota Innovation in the UK

Beyond his leadership for Summit Medical’s home office in Minnesota, McIntosh coordinated supply networks for production of its face shields at Summit Medical’s sister companies under the Innovia Medical umbrella at Eagle Labs in Rancho Cucamonga, Calif. Innovia also leveraged Summit Medical’s face shield design for production at Innovia’s facilities in the United Kingdom, where they are producing over 1.3 million Innovia Face Visors to protect front-line health care workers in UK’s National Health System.

Summit Medical’s Quality and Regulatory team is currently pursuing a CE for the face shields. This would allow Summit Medical to support customer demand in Europe and beyond.

“The health care community has endured untenable delays in securing face shields and other critical PPE due, in part, to components sourced in China,” McIntosh said. “Manufacturing certified, quality face shields with speed and efficiency has been a guiding priority,” McIntosh said. “And unlike others selling unregulated face shields during this limited period of relaxed standards, Summit Medical is an FDA registered medical manufacturer that will sustain its capabilities to meet the continued demand.”

About Summit Medical, an Innovia Medical Company

Summit Medical, an Innovia Medical Company, is a medical device manufacturer located in St. Paul, Minn. Founded in 1982, the company has been serving the global healthcare community for over 30 years. Summit Medical is dedicated to staying on top of industry demands and developing the solutions to meet them throughout all the stages of design, engineering and manufacturing. Innovia Medical combines the experience and expertise of Summit Medical, Network Medical Products, Eagle Labs and DTR Medical t to help our medical professional partners elevate the delivery of care to improve patient outcomes. For more information about Summit Medical and Innovia Medical visit http://www.innoviamedical.com.

Share article on social media or email:

SPIRE Institute & Academy is Prepared And Excited To Safely Reopen


View of the SPIRE IA campus

The most important thing for everyone to know and understand is that we are tracking the incidence of coronavirus-related health issues in the Geneva, Ohio area around the clock, and are prepared to do whatever is necessary to minimize the degree to which it affects the SPIRE community

The COVID-19 outbreak has changed the world we live in almost beyond recognition. Since its onset in March of this year, leadership at SPIRE Institute & Academy (IA) have closely followed the recommendations of the Centers for Disease Control (CDC), the local health department, and Ohio Governor Mike DeWine’s office to prevent the spread of coronavirus, and keep students, campers, parents, guests and SPIRE employees as safe as possible.

SPIRE IA is observing strict requirements to slow or eliminate the spread of the contagion among its school community. Employees, students, campers, parents and guests must wear a mask at all times, complete a CDC questionnaire every day, have their hands stamped daily and have their temperatures taken from one to three times a day.

In addition, the following general guidelines have been put in place to preserve the SPIRE community’s health and well-being:


  • Everyone (employees, students, campers, parents, guests, contractors, delivery personnel) must go through our health and safety screening when they enter the complex.
  • Only SPIRE’s main entrance will be open daily to enter and exit campus.
  • Only people working or training will be allowed in any facility at any time until further notice.
  • All athletes should plan on arrving at least 20 minutes prior to their program, as given the new procedures, there may be a line for athletes waiting to be screened.
  • All minor athletes must have a parent accompany them to the screening so they can sign the appropriate paerwork, prior to any minor athlete being admitted into SPIRE
  • Anyone waiting in a car to drop off or pick up someone will be required to go through our health and safety screening process.
  • All people in our facilities must be at least 6’ apart at all times.
  • All tables in our dining area will be spaced 6’ apart and only one person may sit at each table.
  • Laminated arrows will be taped to the floor showing the only acceptable path for moving through any space on campus.
  • Areas in all buildings not in use will be closed off with yellow caution tape or doors locked.
  • Only enough student desks and chairs will be placed in classrooms to accommodate the number of students enrolled.
  • Signs will be posted throughout the facilities reminding all of safety responsibilities and requirements to remain welcome on campus.
  • Anyone coming on campus to train must arrive and depart wearing their workout clothes including footwear and bring their own sanitizer. Showering on site will not be allowed.
  • Spectators will not be allowed in any building until further notice.
  • If in a building visiting someone’s office, do not cross the blue tape on the floor at the door until invited into the office.
  • There will be no student field trips until further notice.
  • There will be staggered arrival and departure times for all athletes to minimize contact with others.
  • Athlete’s personal belongings upon checking in will be placed in a clear, heavy duty plastic bag with their name on it and placed 6’ apart in sight of where the athlete will be working out.
  • An isolation room will be available.
  • Urgent care and the local hospital are respectively only 5 and 10 minutes away,
  • We have a partnership with the Cleveland Clinic should services be needed 24/7.
  • For families whose children will be boarding, there will be daily health updates or more frequently if needed.

As one of the largest indoor, professional training and competition complexes in the world with more than 750,000 sq. ft. under roof, SPIRE IA is acutely aware of the importance of thorough environmental cleaning and disinfection. SPIRE Facilities Cleanliness Protocol includes the following steps:

  • All campus bathrooms will be sanitized every 4 hours, 7 days a week when buildings are open.
  • All interior and exterior doors will be sanitized every 4 hours.
  • Equipment in SPIRE Fit and Performance will be sanitized after every use.
  • Our Fuel dining and serving area will be sanitized before and after each meal.
  • Vending machines and any other surfaces touched frequently will be sanitized every 4 hours.
  • Classroom desks, countertops and other furniture including all technology will be sanitized nightly.
  • All vehicles will be sanitized before and after any use.
  • All ventilation units will be checked daily to ensure they are working properly.

“The most important thing for everyone to know and understand is that we are tracking the incidence of coronavirus-related health issues in the Geneva, Ohio area around the clock, and are prepared to do whatever is necessary to minimize the degree to which it affects the SPIRE community,” said SPIRE COO Jeff Orloff. “We will continue to adhere to all guidelines from the CDC, and recommendations from Governor DeWine’s office and our local health department to ensure we are creating the safest environment possible on the SPIRE campus.”

About SPIRE

SPIRE Institute & Academy (IA) (http://www.spireinstitute.org) is one of the largest indoor, professional training and competition complexes in the world. With more than 750,000 sq. ft. under roof and a campus of 175 acres, SPIRE has the unique capacity to simultaneously host a world-renowned sports academy, clubs, leagues, tournaments and championship events, no matter the weather or the season.

SPIRE Academy and its expert coaches, teachers and performance trainers offer residential camp and academy training programs in basketball, track and field, swimming and now in esports and drone/robotic/AI/emerging tech as well. The comprehensive mix of professional level training integrates athletics and academics, skills training and performance training and personal and career development in ways that has never been done before. High school and post grad athletes on one campus, pursuing specialty passions ranging from basketball to e-gaming, swimming to drone racing, pole vaulting or sprinting to future opportunities like culinary or cultural arts…is a career development experience that you just won’t find anywhere else in the world today.

SPIRE Institute is the epitome of a ‘real world lab’ for professional, technical and health and wellness research. Like never before, student trainees and elite athletes will have the chance to train, study and be studied side-by-side with weekend warriors, wounded Veterans, Paralympians, Olympians and Special Olympians, as well as juniors, collegians and adults of all ages and ability levels. SPIRE is truly a melting pot of all things relative to long-term training and education development, and all of this delivered within a fun, healthy and inspiring environment. The “SPIRE Way’’ focuses on the development of the whole self – building strong minds, strong bodies and strong character.

Share article on social media or email:

Better than CBD Alone for Pain? Lefa, Innovative New Soothing Topical Loaded with Beta-Caryophyllene and CBD Now Available for Purchase Online via LefaLabs.com


News Image

Whether it’s age-related, sports-related or fitness-related, Lefa is great for adults who live a health-oriented lifestyle and want a natural way to support their body’s Endocannabinoid System’s natural response to inflammation and pain.

Labyrinthe Labs has announced the launch of its brand new and ground-breaking topical joint and muscle support formula called Lefa. A soothing cream designed for fast-action relief of joint and muscle soreness, Lefa is botanically powered by a clinically superior blend of whole plant phytocannabinoids proven to soothe and support tired joints and muscles.

According to the National Institutes of Health, approximately 25.3 million American adults suffer from daily pain and 23.4 million American adults report significant pain. Designed to support the body’s natural Endocannabinoid System which is responsible for regulating inflammation and pain levels, Lefa’s proprietary blend of over 3,000 mg of powerful Beta-Caryophyllene and full spectrum hemp oil with naturally occurring CBD, plus Menthol activates on contact, penetrates deep, and reacts to CB receptors in the skin for immediate and long-lasting support with your very first application.

Lefa’s Full-Spectrum Hemp Oil Tincture Drops are also bountiful with naturally occurring phytocannabinoids supporting the Endocannabinoid System from the inside.

“Every new product we formulate is crafted using proven science and superior innovation providing our customers with unique solutions to an age-old ailment: joint and muscle soreness and discomfort,” said Deborah Ruggerio, Director of Marketing of Labyrinthe Labs. “Whether it’s age-related, sports-related or fitness-related, Lefa is great for adults who live a health-oriented lifestyle and want a natural way to support their body’s Endocannabinoid System’s natural response to inflammation and pain.”

The new products include Joint and Muscle Pain Relief Cream and two non-GMO, vegan and gluten-free, hemp oil tinctures – Peppermint Zen and Natural Namaste – (300mg). All products are manufactured in a certified facility and operating under the strictest of GMP guidelines.

To learn more about Lefa and its products, visit http://www.lefalabs.com.

About Labyrinthe Labs

Labyrinthe Labs was founded in January 2020 as a complete, multi-layered product development, direct response and brand marketing operation. Its team has spent the last 20 years developing new, innovative and scientifically efficacious products with steady mass consumer appeal spanning from baby boomers all the way through millennials.

Share article on social media or email:

Health Therapies Global Inks Distribution Deal with Holista Colltech (ASX:HCT)


“From face masks to a variety of sanitizers with variable levels of potency, no current product has completely alleviated the public’s constant anxiety of the threat of exposure and infection,” said Morell Maison, CEO of Health Therapies Global

Awarded exclusive U.S. marketing and distribution rights to market Natshield™ with Path-Away® sanitizer

Health Therapies Global, an essential health care products distributor, has secured exclusive marketing rights to Holista Colltech’s line of first-class natural ingredients and wellness products in the U.S. and beyond. The deal includes sole distribution rights for the company’s latest blockbuster offering, Natshield™ with Path-Away®, the first plant-based, all-natural and non-alcohol sanitizer completely free of genetically modified organisms (GMOs).

Natshield with Path-Away is suitable for any age group and even pets. It’s a dual-use aerosol which can be safely applied directly on persons or used as an airborne aerosol for surface-based sanitization—offering immediate protection for personal use and the immediate surrounding area.

Health Therapies Global CEO, Morell Maison, believes the key differentiators of Natshield with Path-Away could become a global game changer. His company’s exclusive marketing rights to distribute this next-level disinfecting spray sanitizer also extend beyond the U.S. to include all of North America, Europe, India and Israel—with additional territorial rights in negotiation. Maison is optimistic that the enhanced application features of this new sanitizing spray will encourage a swift response of trial and adoption among the general public.

“From face masks to a variety of sanitizers with variable levels of potency, no current product has completely alleviated the public’s constant anxiety of the threat of exposure and infection,” said Maison. “Traditional hand sanitizers have anti-viral agents, effective for general hygiene purposes, but the risk of coronavirus infection through the skin is minimal. And these sanitizers only eliminate germs for as long as it takes to come in contact with another surface. Once deemed effective against COVID-19, Natshield with Path-Away, can then enter the market as a revolutionary product, providing a long-term, effective, and timely solution.”

About Health Therapies Global

Health Therapies Global is a health products distributor whose global strategy is to facilitate long-term care and solutions in the fight against dozens of harmful pathogens. These include parasitical (soil transmitted helminths (STHs), Plasmodium species) and viruses (respiratory syncytial virus, influenza, human metapneumovirus, human bocavirus, and HIV) to bacteria (Mycobacterium tuberculosis, Salmonella, and methicillin-resistant Staphylococcus aureus). The additional research of its revolutionary product lines is designed to benefit societies in need, while building a long-term and sustainable foundation for the company. The primary mission of Health Therapies Global is the timely distribution and delivery of essential health care products, establishing its status as a valuable and influential partner for the Med/Pharma business industry. Health Therapies Global is a focused, yet diverse, business venture that provides dynamic and pioneering go-to-market strategies. For more information, please visit: http://www.healththerapiesglobal.com.

All Health Therapies Global product claims made on behalf of Natshield with Path-Away are for and on behalf of Holista Colltech (HCT), owners of the global marketing rights for Path-Away, the active ingredient in Natshield. For more information on Holista Colltech, please visit http://www.holistaco.com.

# # #

Health Therapies Global

Morell Maison

CEO

Medical Liaison

Dr. Rajen Manicka

CEO

Holista Colltech (HCT)

Media Contact

Jeff Cheatham

Creative Content

(972) 961-6171

jeff@creativecontent-llc.com

Share article on social media or email: